Amgen Submits Testimony to House Ways & Means Committee

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) today submitted testimony for the record of the House Ways & Means Subcommittee on Health hearing on “Ensuring Kidney Patients Receive Safe and Appropriate Anemia Management Care.”